Today's sweep returned no new approval, label change, recall or safety communication relevant to cardiology. The automated feeds cover drug approvals and enforcement actions, which means device advisories, society standards published as web pages, and Indian regulatory notices do not appear here at all. An empty day should be read as a gap in coverage rather than as a quiet month for regulators.
The standing guidance worth revisiting instead is the American College of Cardiology's 2025 scientific statement on managing peripheral artery disease in adults with diabetes. Its central claim is a diagnostic one: many people with diabetes do not get typical claudication, so peripheral artery disease goes undetected until it presents as chronic limb-threatening ischaemia, and amputation rates in this group are disproportionately high. Alongside that, it documents systematic underuse of guideline-directed medical therapy in patients who have been diagnosed.
Both failures are recognisable in Indian practice, where the diabetic foot clinic and the cardiology clinic often do not talk to each other, and where a patient with neuropathy will not report the symptom that triggers referral. The statement's practical implication is that symptom-triggered detection does not work in this population — screening has to be by examination and by index, not by history.
The statement also flags where the evidence is thin: the optimal timing and method of screening, the use of electronic records for earlier detection, and the lack of standardised trial endpoints for limb outcomes. Those are honest gaps rather than recommendations.
- Examine feet and pulses in every patient with diabetes and vascular risk, rather than waiting for claudication to be reported
- Use an ankle-brachial index where pulses are diminished or the history is unreliable because of neuropathy
- Check that a patient with known peripheral artery disease is actually on guideline-directed medical therapy — underuse is the documented problem
- Treat a diabetic foot ulcer as a marker of systemic atherosclerosis, not only as a local wound
- Remember what the automated feeds miss: device advisories, society web publications and national regulatory notices are not covered here
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for cardiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free